Hologic scores $119M COVID-19 testing contract

By LabPulse.com staff writers

November 2, 2020 -- The U.S. government has awarded a $119 million contract to Hologic to expand its production capacity for COVID-19 molecular tests.

The contract will allow Hologic to provide 13 million tests per month to the U.S. government by January 2022.

Hologic's Panther Fusion SARS-CoV-2 assay and Aptima SARS-CoV-2 assay run on the company's fully automated systems and provide initial results in approximately three hours. They are able to process more than 1,000 tests in 24 hours.

Top companies earn 80% of revenue in IVD market
Most of the revenue in the IVD market is generated by fewer than 20 companies, according to a recent report by IVD market research firm Kalorama Information,...
Hologic debuts pooling protocol for COVID-19 tests
Hologic has validated the use of its Aptima and Panther Fusion molecular diagnostic COVID-19 assays with pooled patient samples and has also applied for...
Molecular diagnostics sales surge in Hologic's Q3
A strong surge in sales of its molecular diagnostics products helped Hologic offset declines in other areas of the company's business in its third fiscal...
World market outlook: COVID-19 testing evolves rapidly, lessons sink in
Worldwide, COVID-19 testing volume was on target to grow 25%-30% from May to June, reports Kalorama Information analyst Justin Saeks.

Copyright © 2020 LabPulse.com

Last Updated ls 11/2/2020 4:02:33 PM